Press release
Spinal Muscular Atrophy Treatment Market Growth Fuelled by Zolgensma®, Spinraza®, and Early Newborn Screening | Pipeline Innovation & Market Size Forecast
"The global spinal muscular atrophy treatment market reached USD 4.40 billion in 2024 and is expected to reach approximately USD 10.09 billion by 2030, growing at a CAGR of 18.0% during the forecast period 2025-2030," according to DataM Intelligence.Key players in the Spinal Muscular Atrophy Treatment Market include Novartis AG (Zolgensma®), F. Hoffmann-La Roche Ltd (Evrysdi®), Genentech USA, Biogen Inc. (Spinraza®), PTC Therapeutics, Inc., Ionis Pharmaceuticals, Inc., Biohaven Ltd, Voyager Therapeutics, Inc., Catalent, Inc., Pfizer Inc., and others. These industry leaders are driving SMA innovation through gene therapy, antisense oligonucleotides, oral modulators, and next-generation pipeline assets expanding indication range and access.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/spinal-muscular-atrophy-sma-treatment-market?jd
Spinal Muscular Atrophy Treatment Market M&A & Strategic Collaborations
• In May 2025, Biogen partnered with Voyager Therapeutics to co-develop next-generation intrathecal gene therapy platforms for SMA, enhancing vector delivery capabilities.
• In June 2025, Novartis announced a licensing deal with Ionis Pharmaceuticals for a new small-molecule modulator targeting muscular function improvement in adolescent SMA patients.
• Genentech expanded its SMA center of excellence in Boston via a strategic investment, enhancing clinical trial infrastructure and patient outreach.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/spinal-muscular-atrophy-sma-treatment-market?jd
Key Growth Drivers & Emerging Opportunities in the Spinal Muscular Atrophy Treatment Market
• Expanded newborn screening programs globally, enabling early detection and timely treatment initiation.
• Gene therapies (Zolgensma®, Evrysdi®) offering durable outcomes with single-dose or daily oral regimens.
• Antisense oligonucleotide advancements enhancing efficacy and targeting SMN2 splicing.
• R&D investment in next-gen delivery systems, including CNS-targeted vectors and oral small molecules.
• Emerging indications in adult and late-onset SMA, broadening patient demographic.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=spinal-muscular-atrophy-sma-treatment-market?jd
Regional Market Drivers in the Spinal Muscular Atrophy Treatment Market
North America leads with widespread SMA screening mandates, high uptake of Zolgensma® and Spinraza®, and strong payer support.
Europe follows with progressive orphan drug policies, growing access programs, and expanded indication approvals.
Asia-Pacific is fast emerging, with government initiatives, registry development, and generics/local manufacturing beginning to scale.
Latin America & MEA are in early stages, with increased advocacy, infrastructure building, and inclusion in global research networks.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis for Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?jd
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Muscular Atrophy Treatment Market Growth Fuelled by Zolgensma®, Spinraza®, and Early Newborn Screening | Pipeline Innovation & Market Size Forecast here
News-ID: 4114339 • Views: …
More Releases from DataM Intelligence 4Market Research LLP

Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expect …
The Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expected to reach US$ 62.63 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
Germany's Medical Technology Market encompasses devices, diagnostic equipment, and digital health solutions. Growth is driven by aging populations, chronic disease prevalence, and healthcare innovation. Hospitals, clinics, and research centers are major end-users. Innovations focus on minimally invasive devices, AI…

Biopesticides Market Projected to Reach US$24.16B by 2032, Growing at a CAGR of …
The Biopesticides Market was valued at US$ 7,734.43 million in 2024 and is projected to reach US$ 24,158.10 million by 2032, registering a CAGR of 15.3% during the forecast period 2025-2032.
The market focuses on the development and use of biological pest control solutions derived from natural organisms, including microorganisms, plant extracts, and bioactive compounds. Biopesticides are widely applied in agriculture, horticulture, and forestry to control pests, enhance crop protection, and…

Japan Wearable Devices Market to Hit $12.31 Billion by 2033, Growing at 12.6% CA …
The Japan wearable devices market reached US$4,026.98 million in 2024 and is expected to reach US$12,310.52 million by 2033, growing at a CAGR of 12.6 % during the forecast period 2025-2033, according to DataM intelligence.
Japan's Wearable Devices Market includes smartwatches, fitness trackers, health monitors, and AR/VR devices. Growth is driven by healthcare monitoring, fitness trends, and IoT adoption. Applications span personal wellness, remote patient monitoring, and industrial safety. Companies and…

Germany Probiotic Drinks Market was US$ 1,006.76 million in 2020 and is expected …
The Germany Probiotic Drinks Market was US$ 1,006.76 million in 2020 and is expected to reach US$ 1,738.01 million in 2028 growing at a CAGR of 7.76% during the forecast period (2025-2028).
Germany's Probiotic Drinks Market includes beverages fortified with live microorganisms promoting gut health and immunity. Growth is driven by wellness trends, functional foods demand, and consumer awareness. Products include yogurts, fermented drinks, and kefir. Retail, health food stores, and…
More Releases for Spinal
Evolving Market Trends In The Spinal Fusion Devices Industry: Advancements In Sp …
The Spinal Fusion Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
What Is the Expected Spinal Fusion Devices Market Size During the Forecast Period?_x000D_
Over the past few years, there has been a significant growth in the spinal fusion devices market. The market is projected…
Key Influencer in the Spinal Fusion Devices Market 2025: Rising Spinal Disorder …
What Is the Forecasted Market Size and Growth Rate for the Spinal Fusion Devices Market?
The market for spinal fusion devices has experienced significant growth in the past couple of years. Expectations are that it will rise from estimates of $7.85 billion in 2024 to approximately $8.31 billion in 2025, giving us a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this notable expansion during the historical period can…
Disposable Spinal Instrument Market: Revolutionizing Spinal Surgery with Hygiene …
Introduction
The medical device market has witnessed a surge in demand for disposable instruments, especially in areas where hygiene, precision, and efficiency are paramount. One such sector experiencing rapid growth is the disposable spinal instrument market. Spinal surgeries, being intricate and requiring high precision, have traditionally relied on reusable instruments. However, growing concerns about hygiene, infection control, and surgical efficiency have accelerated the shift toward disposable spinal instruments. These devices not…
Endoscopic Spinal Surgery Market: Minimally Invasive Solutions for Spinal Disord …
Global Endoscopic Spinal Surgery Market size was valued at US$ 667 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 7.9% through 2022 to 2029, reaching nearly US$ 1137 Mn.
Endoscopic Spinal Surgery Market Overview:
Maximize Market Research is a research firm that has published a detailed analysis of the "Endoscopic Spinal Surgery Market". MMR in-depth market assessments in research reports consider significant technological advancements in…
Spinal Resilience: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
Market Outlook:
Charting Progress: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
The Acute Spinal Cord Injury Drug Pipeline Landscape sets its sights on a decade of advancements poised to redefine the trajectory of spinal resilience. This comprehensive outlook explores the unfolding strategies, innovations, and breakthroughs that promise to revolutionize the landscape of acute spinal cord injury treatment.
Market Drivers:
Neuroregeneration on the Horizon: At the forefront of the Acute Spinal Cord Injury Drug…
Spinal Laminoplasty Market - Revolutionizing spinal care with minimally invasive …
Newark, New Castle, USA: The "Spinal Laminoplasty Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Spinal Laminoplasty Market: https://www.growthplusreports.com/report/spinal-laminoplasty-market/8601
This latest report researches the industry structure, sales, revenue,…